Sign in
  Edit search
Application of a newly developed ELISA for BCAR1 protein for…
Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer.
Application of a newly developed ELISA for BCAR1 protein for prediction of clinical benefit of tamoxifen therapy in patients with advanced breast cancer.
Article, Chapter
Authors: L.C. Dorssers
Publication: Clinical Chemistry, Volume:50, Issue:8, Page(s):-1447
Published: 2004
ISSN: 0009-9147
  Full text availability for this item
View Full Text Source:Clinical Chemistry,Clinical Chemistry,Oxford University Press Journals (UKB 2021-2023) Opens in new Window
Journal:  Clinical Chemistry Source:Oxford University Press Journals (UKB 2021-2023) Opens in new Window
Collection:  Oxford University Press Journals (UKB 2021-2023)
Coverage:
  • 1996~present; volume:42~present;issue:1~present
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item